Predictive Oncology Inc.
POAI | NASDAQ
$4.91
+$0.29 (+6.28%)
At close: May 20, 2026, 12:45 PM ET
Market Data
Market Cap $3.57M
Enterprise Value $-17.1M
Beta 1.35
Average Volume 107.04K
Shares Outstanding (Diluted) 19.69M
Shares Change YoY 116.11%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US74039M4087
Price Performance
Price Change 1M N/A
Price Change 3M N/A
Price Change 6M N/A
Price Change YTD N/A
Price Change 1Y -66.1%
Price Change 3Y -91.7%
Price Change 5Y -98.7%
1M CAGR (ann.) -32.7%
1Y CAGR (ann.) -50.4%
5Y CAGR (ann.) -51.6%
All-Time CAGR -55.7%
Valuation
PE Ratio -0.03
Forward PE 0.05
PEG Ratio 0.00
Forward PEG 0.00
PS Ratio 1.09
Forward PS 0.10
PB Ratio 0.10
P/FCF Ratio -0.69
P/Adj. FCF Ratio -0.61
P/OCF Ratio 8.05
EV/Sales -5.24
EV/EBIT 0.07
EV/EBITDA 0.07
EV/FCF 3.32
Earnings Yield -2962.3%
FCF Yield -144.3%
Adj. FCF Yield -163.5%
Financial Health
Net Cash $20.66M
Total Debt $1.24M
Cash & Short-Term Investments $21.91M
Total Assets $100.38M
Current Ratio 1.45
Quick Ratio 1.45
Debt / Equity Ratio 0.04
Debt / EBITDA -0.00
Debt / FCF -0.24
OCF / Debt 9.63
Interest Coverage 0.00
Altman Z-Score -13.61
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin 7.2%
Operating Profit Margin -1483.9%
EBITDA Margin -7759.2%
Net Profit Margin -7242.4%
FCF Margin -157.7%
Adj. FCF Margin -178.7%
SBC / Revenue 20.9%
SBC Impact (per share) -13.3%
Returns
Return on Assets -235.4%
Return on Equity -2119.0%
Return on Invested Capital -77.6%
Return on Capital Employed -78.5%
Return on Tangible Assets -235.4%
Historical Growth (CAGR)
Revenue CAGR 3Y 28.2%
Revenue CAGR 5Y 18.4%
Revenue CAGR 10Y 21.9%
EPS CAGR 3Y -141.8%
EPS CAGR 5Y -83.3%
EPS CAGR 10Y 21.2%
FCF CAGR 3Y 42.1%
FCF CAGR 5Y 19.4%
FCF CAGR 10Y -5.1%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 0
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Apr 8, 2026
EPS Estimate (next Q) $0.90
EPS Growth Est (next Q) -460.0%
Revenue Est (next Q) $5M
Revenue Growth Est (next Q) 1328.6%
Cash Flow
Operating Cash Flow $11.98M
Free Cash Flow $-5.15M
Adj. Free Cash Flow $-5.83M
FCF Per Share -$0.26
OCF Per Share $0.61
OCF/S Ratio 367.1%
Income Statement
Revenue $3.26M
Gross Profit $233.2K
Operating Income $-48.41M
EBITDA $-253.15M
Net Income $-236.29M
EPS (Diluted) -$145.45
Revenue / Employee $141.85K
Profit / Employee $-10.27M
Employees 23
Add to Watchlist
Select watchlists to add or remove POAI